Summary
Organised by the Council on Basic Science, this biennial event aims to inspire a new generation of basic cardiovascular science leaders taken from among the most gifted science and medical graduates.
Organised by the Council on Basic Science: Inspire a new generation of basic cardiovascular science leaders taken from among the most gifted science and medical graduates - Provide opportunities to meet face-to-face role models from an expert faculty of successful cardiovascular scientists.
ESC Council on Basic Cardiovascular Science contact@escardio.org DD/MM/YYYYOrganised by the Council on Basic Science, this biennial event aims to inspire a new generation of basic cardiovascular science leaders taken from among the most gifted science and medical graduates.
Peter Ferdinandy (HU) and Jolanda van der Velden (NL)
Giuseppina Caligiuri (FR), Gemma Vilahur (SP), Rosalinda Madonna (IT)
Representing the Scientists of Tomorrow - Niels Voigt (DE), and Jyoti Patel (UK)
18.00 Welcome – Course Directors
18.15 Opening keynote plenary lecture - Targeting inflammation in hypertension - T Guzik (Glasgow, UK)
Session I: Heart Failure (Chair: J van der Velden)
09.00 Pathophysiology of HFpEF, HFrEF, and HFmEF - J van der Velden (Amsterdam, NL)
09.45 Central role of mitochondrial dysfunction in heart failure - F Di Lisa (Padua, IT)
This session is sponsored by the COST Action (EU-CARDIOPROTECTION CA16225)
Session II: Cardiac and vascular development (Chair: G Cagliuri)
11.00 Cardiac development: regulating heart rate - L Miquerol (Marseille Cedex 9, FR)
11.45 Vascular develoment and remodeling - P Lacolley (Vandoeuvre-Les-Nancy, FR)
Session III: Thrombosis and coagulation (Chair: G Vilahur)
13.30 Atherothrombosis - H Ten Cate (Maastricht, NL)
14.15 Antithrombotic agents - R De Caterina (Pisa, IT)
Session IV: Publishing your research (Chair: JD Pearson)
15.15 Getting the experimental design and statistical analysis right - DJ Duncker (Rotterdam, NL)
16.00 Writing the paper: what the journal editors expect - T Guzik (Glasgow, GB)
16.50 Writing ECI fellowships and grants - JD Pearson (London, GB)
Session V: Cardiomyopathies (Chair: J van der Velden)
09.00 Clinical view on pediatric and adult cardiomyopathy - M Michels (Rotterdam, NL)
09.45 Genetic therapies to treat cardiomyopathies - L Carrier (Hamburg, DE)
Session VI: The immune response in vascular pathologies (Chair: J Patel)
11.00 The roles innate and adaptive immune cells - G Caligiuri (Montrouge, FR)
11.45 Targeting immune receptors - N Gerdes (Dusseldorf, DE)
13.10 Industry presentation - AstraZeneca - Cardiac regeneration and repair for treatment of heart failure - K Jennbacken (Kallered, SE)
Session VII: Arrhythmic disorders (Chair: J van der Velden)
13.30 Genetics and pathophysiology of cardiac arrhythmias - K Odening (Freiburg, DE)
14.15 Role of calcium signalling in rhythm disorders - N Voigt (Goettingen, DE)
Session VIII: How to turn basic science into business? (Chair: P Ferdinandy)
15.15 How to boost bioenterpeneurship: need to protect intellectual property – N Boubenna (Paris, FR)
16.00 Innovations and technology transfer: success stories - G Caligiuri (Montrouge, FR)
Session IX: Cardioprotection (Chair: P Ferdinandy)
09.00 Ischemia-reperfusion injury and cardioprotection: opportunities and challenges for clinical translation - G Heusch (Essen, DE)
9.45 Importance of comorbidities and risk factors in studies of cardioprotection - R Schulz (Giessen, DE)
This session is sponsored by the COST Action (EU-CARDIOPROTECTION CA16225)
Session X: Novel RNA- and cell-based therapies to target cardiovascular disease (Chair: G Vilahur)
11.00 Non-coding RNA targeting therapies - R Boon (Frankfurt, DE)
11.45 Targeting atherosclerosis and ischemic heart disease by immune modulating cell therapeutics - R Madonna (Chieti, IT)
Session XI: Drug cardiotoxicity (Chair: G Caligiuri)
13.30 Hidden cardiotoxocity – paradigm change in safety screening of drugs? - P Ferdinandy (Budapest, HU)
14.15 Cardiotoxicity and cancer - P Ameri (Genova, IT)
Session XII: Finding new drug targets by unbiased methods: the worlds of omics and bioinformatics (Chair: P Ferdinandy)
15.15 The advantages and limitations of proteomics and metabolomics - M Mayr (London, GB)
16.45 Epigenomics and transcriptomics - C Perrino (Napoli, IT)
Session XIII: Building your career (Chair: J Patel / N Voigt)
09.00 Advice from the faculty and open discussion - G Vilahur (Barcelona, ES) / R Madonna (Chieti, IT) / P Ferdinandy (Budapest, HU)
Session XIV: Extracellular vesicles (Chair: G Vilahur)
10.30 Exosomes in cardiac health and diseases - SM Davidson (London, GB)
11.15 Extracellular vesicles for diagnostics and therapeutics: where do we stand? -
J Sluijter (Utrecht, NL)
This session is sponsored by the COST Action (EU-CARDIOPROTECTION CA16225)
Session XV Closing keynote plenary lecture (Chair: J van der Velden)
12.15 Keynote plenary lecture: Current state of tissue engineering and stem cells - T Eschenhagen (Hamburg, DE)
13.00-14.00 Selected Poster presentation and prize session
Discover more about the ESC Council on Basic Cardiovascular Science
This session is sponsored by the COST Action (EU-CARDIOPROTECTION CA16225)
This educational programme is supported by Amgen and AstraZeneca in the form of an educational grant. The scientific content has not been influenced in any way by its sponsors.
Find out more